RECORDATI: SUMMARY REPORT OF THE VOTES - ORDINARY GENERAL MEETING OF THE SHAREHOLDERS 22.04.2024
April 24, 2024 at 11:10 pm IST
Share
NEWS RELEASE
RECORDATI: SUMMARY REPORT OF THE VOTES - ORDINARY GENERAL MEETING OF THE SHAREHOLDERS 22.04.2024
Milan, 24th April 2024 - Please be informed that the summary report of the voting results related to the resolutions approved by the Ordinary General Meeting of the Shareholders on 22nd April 2024, pursuant to article 125-quater of the Legislative Decree 58/98, is available to the public on the Company's website (www.recordati.it, in the area "Investors", section "Shareholder Information") and on the "1info" storage mechanism (www.1info.it).
Recordati (Reuters RECI.MI, Bloomberg REC IM) is an international pharmaceutical group listed on the Italian Stock Exchange (ISIN IT 0003828271) uniquely structured to bring treatment across specialty and primary care, consumer healthcare, and rare diseases. We believe that health, and the opportunity to live life to the fullest, is a right, not a privilege. We want to support people in unlocking the full potential of their lives. We have fully integrated operations across research & development, chemical and finished product manufacturing through to commercialisation and licensing. Established in 1926, Recordati operates in approximately 150 countries across EMEA, Americas and APAC regions. At the end of 2023, Recordati employed over 4,450 people and consolidated revenue of € 2,082.3 million.
For more information, please visit www.recordati.com
Investor Relations
Investor Relations
Media Relations Brunswick:
Eugenia Litz
Lucia Abbatantuoni
Barbara Scalchi / Andrea Mormandi
+44 7824 394 750
+39 337 1025645
+39 02 9288 6200
investorelations@recordati.it
investorelations@recordati.it
recordati@brunswickgroup.com
RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.p.A.
Registered office VIA M. CIVITALI, 1 20148 MILAN, ITALY TEL. +39 0248787.1 FAX +39 0240073747
SHARE CAPITAL € 26,140,644.50 fully paid up
BUSINESS REGISTER OF MILAN, MONZA, BRIANZA and LODI 00748210150
TAX CODE/VAT NO. 00748210150
Company subject to management and coordination by Rossini Luxembourg S.àr.l
Attachments
Original Link
Original Document
Permalink
Disclaimer
Recordati Industria Chimica e Farmaceutica S.p.A. published this content on
24 April 2024 and is solely responsible for the information contained therein. Distributed by
Public, unedited and unaltered, on
24 April 2024 17:39:05 UTC.
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (32.1%).
Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).